SMAIO SA has announced the signing of a new distribution agreement with Orthofix, a global medical technology company focused on musculoskeletal pathologies. The agreement will allow Orthofix to distribute SMAIO's open platform KEOPS-4ME, which is designed for customized implant solutions, in the U.S. market. This collaboration is part of SMAIO's strategy to expand its presence in the United States and aims to facilitate clinical adoption of SMAIO's solutions through Orthofix's hospital network.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SMAIO SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20251021803107) on October 22, 2025, and is solely responsible for the information contained therein.